title: NICE guidance on erlotinib for the maintenance treatment of non-small-cell lung cancer.
authors.forename: Fiona
authors.initials: F
authors.lastname: Rinaldi
authors.forename: Elisabeth
authors.initials: E
authors.lastname: George
authors.forename: Peter
authors.initials: P
authors.lastname: Clark
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D003226:Congresses as Topic; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D000069347:Erlotinib Hydrochloride; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D006113:United Kingdom
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride